Lactam glycogen phosphorylase inhibitors and method of use
US7425550B2 · kind B2 · utility
5Cited by
57References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 13, 2006 |
| Grant date | Sep 16, 2008 |
| Priority date | — |
| Expiry date | Jul 29, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A compound of formula I is provided having the structurewherein Further provided is a method for treating diabetes and related diseases employing the above compound, either alone or in combination with another therapeutic agent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.